Avai Bio (AVAI) Depreciation & Amortization (IS) (2018 - 2024)
Avai Bio's Depreciation & Amortization (IS) history spans 6 years, with the latest figure at $27849.0 for Q1 2024.
- For Q1 2024, Depreciation & Amortization (IS) rose 628.27% year-over-year to $27849.0; the TTM value through Mar 2024 reached $57534.0, up 145.7%, while the annual FY2025 figure was $74320.0, 3.42% down from the prior year.
- Depreciation & Amortization (IS) for Q1 2024 was $27849.0 at Avai Bio, up from $10267.0 in the prior quarter.
- Across five years, Depreciation & Amortization (IS) topped out at $27849.0 in Q1 2024 and bottomed at $3824.0 in Q1 2023.
- The 4-year median for Depreciation & Amortization (IS) is $11129.5 (2022), against an average of $11874.2.
- The largest annual shift saw Depreciation & Amortization (IS) skyrocketed 19178.67% in 2020 before it fell 23.79% in 2023.
- A 4-year view of Depreciation & Amortization (IS) shows it stood at $14124.0 in 2020, then plummeted by 72.92% to $3825.0 in 2022, then skyrocketed by 168.42% to $10267.0 in 2023, then soared by 171.25% to $27849.0 in 2024.
- Per Business Quant, the three most recent readings for AVAI's Depreciation & Amortization (IS) are $27849.0 (Q1 2024), $10267.0 (Q4 2023), and $10317.0 (Q3 2023).